Generalized Anxiety Disorder

use the link to see the case and be able to elaborate it

Psychopharmacologic Approaches to Treatment of Psychopathology (waldenu.edu)
White Male With AnxietyThe Assignment: 5 pages + references pages

Examine
Case Study: A Middle-Aged Caucasian Man With Anxiety.You will be asked to make three decisions concerning the medication to prescribe to this patient. Be sure to consider factors that might impact the patients pharmacokinetic and pharmacodynamic processes.

At each decision point, you should evaluate all options before selecting your decision and moving throughout the exercise. Before you make your decision, make sure that you have researched each option and that you evaluate the decision that you will select. Be sure to research each option using the primary literature.

Introduction to the case (1 page)

Briefly explain and summarize the case for this Assignment. Be sure to include the specific patient factors that may impact your decision making when prescribing medication for this patient.

Decision #1 (1 page)

Which decision did you select?
Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #2 (1 page)

Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Decision #3 (1 page)

Why did you select this decision? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
Why did you not select the other two options provided in the exercise? Be specific and support your response with clinically relevant and patient-specific resources, including the primary literature.
What were you hoping to achieve by making this decision? Support your response with evidence and references to the Learning Resources (including the primary literature).
Explain how ethical considerations may impact your treatment plan and communication with patients. Be specific and provide examples.

Conclusion (1 page)

Summarize your recommendations on the treatment options you selected for this patient. Be sure to justify your recommendations and support your response with clinically relevant and patient-specific resources, including the primary literature.

one of the references to use and has to appear in the work:
[emailprotected]: FDA-Approved Drugs

Not explain altogether. Write each question with its answer individually.

using formal APA writing convention, using the7th Edition

References at least 5 and not more than 5 years ago

Plagiarism free work. Thank you

OTHER REFERENCES MAYBE HELP
Bui, E., Pollack, M. H., Kinrys, G., Delong, H., Vasconcelos e S, D., & Simon, N. M. (2016). The pharmacotherapy of anxiety disorders. In T. A. Stern, M. Favo, T. E. Wilens, & J. F. Rosenbaum. (Eds.),
Massachusetts General Hospital psychopharmacology and neurotherapeutics(pp. 6171). Elsevier.

American Psychiatric Association. (2010a).
Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/acutestressdisorderptsd.pdf

American Psychiatric Association. (2010c).
Practice guideline for the treatment of patients with panic disorder(2nd ed.). https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/panicdisorder.pdf

Bendek, D. M., Friedman, M. J., Zatzick, D., & Ursano, R. J. (n.d.).
Guideline watch (March 2009): Practice guideline for the treatment of patients with acute stress disorder and posttraumatic stress disorder. https://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/acutestressdisorderptsd-watch.pdf

Cohen, J. A. (2010). Practice parameter for the assessment and treatment of children and adolescents with posttraumatic stress disorder.
Journal of the American Academy of Child and Adolescent Psychiatry, 49(4), 414430. https://jaacap.org/action/showPdf?pii=S0890-8567%2810%2900082-1

Davidson, J. (2016). Pharmacotherapy of post-traumatic stress disorder: Going beyond the guidelines.
British Journal of Psychiatry,
2(6), e16e18. 10.1192/bjpo.bp.116.003707. http://bjpo.rcpsych.org/content/2/6/e16

Hamilton, M. (1959).
Hamilton Anxiety Rating Scale (HAM-A). PsycTESTS. https://doi.org/10.1037/t02824-0

Ostacher, M. J., & Cifu, A. S. (2019). Management of posttraumatic stress disorder.
JAMA, 321(2), 200201. https://doi.org/10.1001/jama.2018.19290

Strawn, J. R., Wehry, A. M., DelBello, M. P., Rynn, M. A., & Strakowski. S. (2012). Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder.
Depression and Anxiety, 29(4), 328339. https://doi.org/10.1002/da.21913

SHOW MORE…

Chapter 11, Case 1

Chapter 11, Case 1
Lotus is a 36-year-old Asian American female who recently started a new executive position with an advertising firm. While she loves her new job and the field of advertising, she admits that the new schedule is grueling and that she often doesnt get home until quite late. She has noticed that it is difficult for her to relax before getting to bed and her mind often wanders to the many tasks she needs to complete when she returns to work in the morning. These racing thoughts result in significant initial insomnia, causing her to be alert for nearly an hour or more before she is able to fall asleep. When questioned about these symptoms, she claims that she has never seen a therapist before, doesnt consider herself to be anxious or depressed, and has never had a problem with sleeping in the past. There are no worries of money or health-related issues, and she claims to enjoy her job and the people with whom she works. She even does not find these thoughts unpleasant, as she uses the time to plan her next day. She admits that they are just a bit intrusive and that she really needs to wind down and get more rest.
Questions:Remember to answer these questions from your textbooks and clinical guidelines to create your evidence-based treatment plan. At all times, explain your answers.

Summarize the clinical case.
What is the DSM5 diagnosis? Identify the rationale for your diagnosis using the DSM5 diagnostic criteria.
According to the clinical guidelines, which one pharmacological treatment is most appropriate to prescribe? Include the medication name, dose, frequency and rationale for this treatment.
According to the clinical guidelines, which one non-pharmacological treatment would you prescribe? (exclude psychotherapy modalities) Include the risk and benefits of the chosen rationale for this treatment.
Include an assessment of medication’s appropriateness, cost, effectiveness, safety, and potential for patient adherence.
Use a local pharmacy (miami, USA) to research the cost of the medication. Use great detail when answering questions 3-5.

Submission Instructions:
at least 500 words ( 2 complete pages of content) formatted and cited in current APA style 7 ed with support from at least 3 academic sources which need to be journal articles or books from 2018 up to now. NO WEBSITES allowed for reference entry. Include doi, page numbers, etc. Plagiarism must be less than 10%.